Completed

Buprenorphine vs. Monetary Alternative in Medication Management

What is being tested

Data Collection

Who is being recruted

Narcotic-Related Disorders+2

+ Mental Disorders

+ Opioid-Related Disorders

From 34 to 51 Years

See all eligibility criteria

How is the trial designed

Treatment Study

Phase 2

Interventional

Study Start: May 1993

See protocol details

Summary

Principal SponsorNational Institute on Drug Abuse (NIDA)

Last updated: January 27, 2026

Sourced from a government-validated database.Claim as a partner

Study start date: May 1, 1993

Actual date on which the first participant was enrolled.

This study focuses on individuals receiving buprenorphine, a medication used to treat opioid addiction. The main goal is to understand how these individuals adjust their medication intake when offered a monetary alternative to buprenorphine. This research is important as it may provide insights into how to improve treatment strategies for opioid addiction, potentially leading to better care and outcomes for those affected. During the study, participants are given the option to choose between buprenorphine and a monetary reward. The study measures various outcomes including the drug's effect characteristics using a tool called ARCI, the participants' choice between money and medication, opioid withdrawal symptoms, and the participants' subjective estimation of their dosage. These measurements help evaluate the effectiveness and impact of the treatment approach.

Official TitleAlternate Day Buprenorphine Administration, Phase X

NCT00000233

Principal SponsorNational Institute on Drug Abuse (NIDA)

Last updated: January 27, 2026

Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.

Conditions

Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 34 to 51 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Narcotic-Related DisordersMental DisordersOpioid-Related DisordersSubstance-Related DisordersChemically-Induced Disorders

Criteria

Please contact site for information.

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Treatment Research Center

Burlington, United StatesOpen Treatment Research Center in Google Maps

CompletedOne Study Center